OptimizeRx Corp
OPRX· Nasdaq
OPRXOptimizeRx Corp
Filed Nov 14, 2012 · 10-Q · 45 days after period end · 0001255294-12-000810
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $453.15K | $191.59K | $40.68K |
| Net Income | -$106.17K | -$1.22M | — |
| EPS Diluted | -$0.01 | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
OptimizeRx Corp · CIK 1448431 · Engraved from SEC EDGAR
ended Sep 30, 2012 · filed Nov 14, 2012 · 45 d after period end
